Public Health

Using a large language model AI, biotech startup Profluent has created new antimicrobial proteins.

Researchers have engineered bacteria to create a “living medicine” against a nasty respiratory bug.

Moderna’s mRNA RSV vaccine for adults looks to be over 80% effective, based on early data from a large phase 3 trial.

A “morning after” antiviral nasal spray could be created using new knowledge about how SARS-CoV-2 invades your nose.

A new universal flu vaccine candidate that uses mRNA to target all known flu subtypes looks promising in animal models.

Instead of replacing sugar, Wyss scientists had an idea: what if they change sugar to make it healthier?

Researchers tracked 25,241 non-exercisers wearing accelerometers to find out of brief bursts of activity lowered their risk of dying.

Researchers have identified a compound capable of stopping multiple coronaviruses in cell and tissue models.

While treatments are available for HCV-related infections, they are expensive, hard to access, and do not protect against reinfection.

The risk of death from influenza has declined over time, but globally, hundreds of thousands of people still die from the disease each year.